BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8814249)

  • 21. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
    Yagi J; Baron J; Buxser S; Janeway CA
    J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway.
    Fischer H; Gjörloff A; Hedlund G; Hedman H; Lundgren E; Kalland T; Sjögren HO; Dohlsten M
    J Immunol; 1992 Apr; 148(7):1993-8. PubMed ID: 1347547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
    Baum D; Yaron R; Yellin MJ
    Cell Immunol; 1998 Nov; 190(1):12-22. PubMed ID: 9826442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.
    Nickoloff BJ; Mitra RS; Green J; Zheng XG; Shimizu Y; Thompson C; Turka LA
    J Immunol; 1993 Mar; 150(6):2148-59. PubMed ID: 8450207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling of receptor mimics that inhibit superantigen pathogenesis.
    Möllhoff M; Zanden HB; Shiflett PR; Gupta G
    J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1.
    Trede NS; Castigli E; Geha RS; Chatila T
    J Immunol; 1993 Jun; 150(12):5604-13. PubMed ID: 8515079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligation of MHC class I and class II molecules can lead to heterologous desensitization of signal transduction pathways that regulate homotypic adhesion in human lymphocytes.
    Wagner N; Engel P; Vega M; Tedder TF
    J Immunol; 1994 Jun; 152(11):5275-87. PubMed ID: 7514635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional and translational control of TNF-alpha gene expression in human monocytes by major histocompatibility complex class II ligands.
    Espel E; Garcia-Sanz JA; Aubert V; Menoud V; Sperisen P; Fernández N; Spertini F
    Eur J Immunol; 1996 Oct; 26(10):2417-24. PubMed ID: 8898955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcal toxins bind to different sites on HLA-DR.
    Chintagumpala MM; Mollick JA; Rich RR
    J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.